Teva Pharmaceutical Industries Limited

Assia Chemical Industries Ltd.

Pliva Hrvatska D.o.o.

Other

Plus Chemicals Sa

Galluzzo, Christian

Canavesi, Augusto

Biljan, Tomislav

Tiseni, Paolo, Simone

Tomislav Biljan

Jasna Dogan

Mihaela Tuksar

Sara Morasi Pipercic

Maja Matanovic Skugor

Marina Ratkaj

Tina Mundorfer

Yi Wang

Dijana Skalec Samec

Nikolina Janton

Augusto Canavesi

Miroslav Zegarac

Leonid Metsger

Moris Mihovilovic

Nea Baus

Nea Baus Topic

Paolo Simone Tiseni

Christian Galluzzo

Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.

Solid state forms of rucaparib and of rucaparib salts

The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.

Processes and intermediates for the preparation of Pimavanserin

The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes. 

Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydro bromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets.

Crystalline forms of Prasugrel salts

Salts of prasugrel were prepared including, for example, crystalline forms of prasugrel hydrobromide. These salts are useful, for example, in medicaments that inhibit the aggregation of platelets.

The invention provides Saxagliptin Schiff bases, polymorphs of Saxagliptin and (1S,3S,5S)-2-[(2S)-2-propan-2-ylideneamino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, processes for preparing Saxagliptin hydrates, and pharmaceutical compositions thereof.

Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof

Growing community of inventors

Krizevci, Croatia

Tomislav Biljan